Erectile dysfunction among hypertensive men in a rapidly developing country

Indian Journal of Urology

Volumn 23, Issue 2, 2007, Pages 109-113

  Bener, Abdulbari ^a,b   Al Ansari, Abdullah ^b   Afifi, Mustafa ^c   Krishna, Prasad V ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c MINISTRY OF HEALTH   (Oman)

Author keywords

Epidemiology; Erectile dysfunction; Hypertension; International index of erectile function; Qatari s population; Risk factors

Indexed keywords

EID: 34248374276     PISSN: 09701591     EISSN: None     Source Type: Journal    
DOI: 10.4103/0970-1591.32057     Document Type: Article

References (26)

1. WHO. Regional Office for the Eastern Mediterranean. Demographic and health Indicators for Countries of the Eastern Mediterranean. WHO-EM/HST/200/E. 2005.
2. Bener A, Al Suwaidi J, Al-Jaber K, Al-Marri S, Dagash MH, Elbagi IA. The prevalence of hypertension and its associated risk factors in a newly developed country. Saudi Med J 2004;25:918-22.
3. Whitworth JA; World Health Organization, International Society of Hypertension Writing Croup. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003;21:1983-92.
4. Giuliano FA, Leriche A, Jaudinot EO, de Cendre AS. Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension or both. Urology 2004;64:1196-201.
5. Ayta IA, Mckinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2005 and some possible policy consequences. BJU Int 1999;84:50-6.
6. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts male aging study. J Urol 1994;151:54-61.
7. American Heart Association. At-a-glance summary tables: Men and cardiovascular diseases. Available from: http:/www.americanheart.org/ downloadable/heart/1109000828619FS07MN05. [Last accessed on 2006 Nov 30].
8. Burchardt M, Burchardt T, Baer L, Kiss AJ, Pawar RV, Shabsigh A, et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000;164:1188-91.
9. Jensen J, Lendorf A, Stimpel H, Frost J, Ibsen H, Rosenkilde P. Thhe prevalence and etiology of impotence in 101 male hypertensive outpatients. Am J Hypertens 1999;12:271-5.
10. Mittawae B, El-Nashaar AR, Fouda A, Magdy M, Shamloul R. Incidence of erectile dysfunction in 800 hypertensive patients: A multicenter Egyptian national study. Urology 2006;67:575-8.
11. Kushiro T, Takahashi A, Saito F, Otsuka Y, Soma M, Kurihara T, et al. Erectile dysfunction and its influence on quality of life in patients with essential hypertension. Am J Hypertens 2005;18:427-30.
12. Cuellar de Leon AJ, Ruiz Garcia V, Campos Gonzalez JC, Perez Hoyos S, Brotons Multo F. Prevalence erectile dysfunction in patients with hypertension. Med Clin (Bare) 2002;119:521-6.
13. Lundberg P, Biriell C. Impotence-the drug risk factor. Int J Impot Res 1993;5:237-9.
14. Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, et al. Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients. Asian J Androl 2006;8:177-82.
15. Aranda A, Ruilope LM, Calvo A, Luque M, Coca A, Gil de Miguel A. Erectile dysfunction in essential arterial hypertension and effects of sildenafil: Results of a Spanish national study. Am J Hypertens 2004;17:139-45.
16. Roth A, Kalter-Leibovici O, Kerbis Y, Tenenbaum-Koren E, Clien J, Sobol T, et al. Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension or both diseases: A community survey among 1,412 Israeli men. Clin Cardiol 2003;26:25-30.
17. Doumas M, Tsakiris A, Douma S, Grigorakis A, Papadopoulos A, Hounta A, et al. Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects. J Androl 2006;27:469-77.
18. Rosen RC, Riley A, Wagner C, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
19. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
20. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-51.
21. Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S. Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire. Eur Urol 2005;47:80-6.
22. Shaeer KZ, Osegbe DN, Siddiqui SH, Razzaque A, Classer DB, Jaguste V. Prevalence of erectile dysfunction and its correlates among men attending primary care clinics in three countries: Pakistan, Egypt and Nigeria. Int J Impot Res 2003;15:58-14.
23. Keene LC, Davies PH. Drug-related erectile dysfunction. Adverse Drug React Toxicol Rev 1999;18:5-24.
24. Freis ED. Current status of diuretics, β-blockers, α-blockers and α-β-blockers in the treatment of hypertension. Med Clin North Am 1997;81:1305-7.
25. Fogari R, Preti P, Derosa G, Marasi G, Zoppi A, Rinaldi A, et al. Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men. Eur J Clin Pharmacol 2002;58:177-80.
26. Calhoun DA, Zaman MA, Nishizaka MK. Resistant hypertension. Curr Hypertens Rep 2002;4:221-8.